Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Neuroinflammation ; 9: 119, 2012 Jun 07.
Article in English | MEDLINE | ID: mdl-22676642

ABSTRACT

BACKGROUND: The myelin sheath provides electrical insulation of mechanosensory Aß-afferent fibers. Myelin-degrading matrix metalloproteinases (MMPs) damage the myelin sheath. The resulting electrical instability of Aß-fibers is believed to activate the nociceptive circuitry in Aß-fibers and initiate pain from innocuous tactile stimulation (mechanical allodynia). The precise molecular mechanisms, responsible for the development of this neuropathic pain state after nerve injury (for example, chronic constriction injury, CCI), are not well understood. METHODS AND RESULTS: Using mass spectrometry of the whole sciatic nerve proteome followed by bioinformatics analyses, we determined that the pathways, which are classified as the Infectious Disease and T-helper cell signaling, are readily activated in the nerves post-CCI. Inhibition of MMP-9/MMP-2 suppressed CCI-induced mechanical allodynia and concomitant TNF-α and IL-17A expression in nerves. MMP-9 proteolysis of myelin basic protein (MBP) generated the MBP84-104 and MBP68-86 digest peptides, which are prominent immunogenic epitopes. In agreement, the endogenous MBP69-86 epitope co-localized with MHCII and MMP-9 in Schwann cells and along the nodes of Ranvier. Administration of either the MBP84-104 or MBP68-86 peptides into the naïve nerve rapidly produced robust mechanical allodynia with a concomitant increase in T cells and MHCII-reactive cell populations at the injection site. As shown by the genome-wide expression profiling, a single intraneural MBP84-104 injection stimulated the inflammatory, immune cell trafficking, and antigen presentation pathways in the injected naïve nerves and the associated spinal cords. Both MBP84-104-induced mechanical allodynia and characteristic pathway activation were remarkably less prominent in the T cell-deficient athymic nude rats. CONCLUSIONS: These data implicate MBP as a novel mediator of pain. Furthermore, the action of MMPs expressed within 1 day post-injury is critical to the generation of tactile allodynia, neuroinflammation, and the immunodominant MBP digest peptides in nerve. These MBP peptides initiate mechanical allodynia in both a T cell-dependent and -independent manner. In the course of Wallerian degeneration, the repeated exposure of the cryptic MBP epitopes, which are normally sheltered from immunosurveillance, may induce the MBP-specific T cell clones and a self-sustaining immune reaction, which may together contribute to the transition of acute pain into a chronic neuropathic pain state.


Subject(s)
Epitopes, T-Lymphocyte/adverse effects , Immunodominant Epitopes/adverse effects , Myelin Basic Protein/physiology , Pain/immunology , T-Lymphocyte Subsets/immunology , Amino Acid Sequence , Animals , Epitopes, T-Lymphocyte/physiology , Female , HEK293 Cells , Humans , Immunodominant Epitopes/physiology , Molecular Sequence Data , Monitoring, Immunologic/adverse effects , Pain/etiology , Pain/pathology , Pain Measurement/methods , Rats , Rats, Nude , Rats, Sprague-Dawley , T-Lymphocyte Subsets/pathology
2.
Mol Biochem Parasitol ; 89(1): 123-35, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9297706

ABSTRACT

Ocular onchocerciasis results from immune recognition of parasite proteins released into the eye by degenerating microfilariae. Previous studies have shown that pathology similar to human ocular onchocerciasis can be induced in sensitized mice by intracorneal injection with Onchocerca volvulus antigens. In the current study, we used this murine model to map the segments of O. volvulus protein disulfide isomerase (OvPDI) associated with the development of corneal pathology. Subclones of OvPDI were constructed encompassing one or more predicted T cell epitopes. Keratitis was induced in BALB/c mice after subcutaneous immunizations with OvPDI, followed by intracorneal challenge of OvPDI constructs. Truncated OvPDI proteins containing amino acids 450-481 of OvPDI were found to induce keratitis, whereas constructs that did not include this region did not induce corneal pathology. Consistent with this observation, two peptides derived from the 450-481 region stimulated T cell proliferation to a greater degree than control carrier protein. DNA sequence analysis of cDNAs encoding OvPDI from blinding and non-blinding strains of O. volvulus indicated no differences in the primary amino acid sequence of the 450-481 domain. Immunization of animals with OvPDI induced antibodies recognizing a 55 kDa host protein, identical to the predicted molecular weight of the mouse PDI homologue. Together, these data implicate specific antigenic epitopes of OvPDI in the development of O. volvulus mediated corneal pathology.


Subject(s)
Cornea/pathology , Immunodominant Epitopes/adverse effects , Keratitis/pathology , Onchocerca volvulus/genetics , Onchocerca volvulus/immunology , Onchocerciasis, Ocular/pathology , Recombinant Fusion Proteins/adverse effects , Amino Acid Sequence , Animals , Antigens, Helminth/adverse effects , Antigens, Helminth/genetics , Antigens, Helminth/immunology , Carrier Proteins/adverse effects , Carrier Proteins/genetics , Carrier Proteins/immunology , Cornea/immunology , Epitope Mapping , Immunodominant Epitopes/genetics , Immunodominant Epitopes/immunology , Keratitis/etiology , Keratitis/immunology , Lymphocyte Activation , Maltose-Binding Proteins , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Onchocerciasis, Ocular/etiology , Onchocerciasis, Ocular/immunology , Peptides/chemical synthesis , Peptides/immunology , Recombinant Fusion Proteins/immunology , Species Specificity
3.
J Immunol ; 174(11): 6854-62, 2005 Jun 01.
Article in English | MEDLINE | ID: mdl-15905527

ABSTRACT

Peptide immunotherapy both activates and suppresses the T cell response against known peptide Ags. Although pretreatment with VP2(121-130) peptide inhibits the development of antiviral CTL specific for the immunodominant D(b):VP2(121-130) epitope expressed during acute Theiler's murine encephalomyelitis virus infection, i.v. injection of this same peptide or MHC tetramers containing the peptide during an ongoing antiviral CTL response results in a peptide-induced fatal syndrome (PIFS) within 48 h. Susceptibility to PIFS is dependent on peptide-specific CD8(+) T cells, varies among inbred strains of mice, and is not mediated by traditionally defined mechanisms of shock. Analyses using bone marrow chimeras and mutant mice demonstrate that susceptibility to PIFS is determined by the genotype of bone marrow-derived cells and requires the expression of perforin. Animals responding to peptide treatment with PIFS develop classical stress responses in the brain. These findings raise important considerations for the development of peptide therapies for active diseases to modify immune responses involving expanded populations of T cells. In summary, treatment with peptides or MHC-tetramers during a peptide-specific immune response can result in a fatal shock-like syndrome. Susceptibility to the syndrome is genetically determined, is mediated by CD8(+) T cells, and requires expression of perforin. These findings raise concerns about the use of peptides and MHC tetramers in therapeutic schemes.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/virology , Capsid Proteins/adverse effects , Cardiovirus Infections/immunology , Cardiovirus Infections/mortality , Epitopes, T-Lymphocyte/adverse effects , Immunodominant Epitopes/adverse effects , Theilovirus/immunology , Animals , Antigen Presentation/genetics , CD8-Positive T-Lymphocytes/metabolism , Capillary Permeability/genetics , Capillary Permeability/immunology , Capsid Proteins/administration & dosage , Capsid Proteins/immunology , Cardiovirus Infections/genetics , Cardiovirus Infections/physiopathology , Epitopes, T-Lymphocyte/administration & dosage , Epitopes, T-Lymphocyte/immunology , Female , Genetic Predisposition to Disease/genetics , H-2 Antigens/immunology , Histocompatibility Antigen H-2D , Histocompatibility Antigens Class II/genetics , Histocompatibility Antigens Class II/physiology , Immunity, Innate/genetics , Immunization Schedule , Immunodominant Epitopes/administration & dosage , Immunodominant Epitopes/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Peptide Fragments/administration & dosage , Peptide Fragments/adverse effects , Peptide Fragments/immunology , Receptors, Interferon/deficiency , Receptors, Interferon/genetics , Syndrome , Interferon gamma Receptor
4.
Clin Exp Immunol ; 98(3): 408-13, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7994905

ABSTRACT

Latex allergy is an occupational hazard for health care workers. Extractable latex proteins are known to be allergenic, but most latex allergens have not been specifically identified. The purpose of this study was to characterize the IgE response of latex-allergic patients to latex proteins and to identify common protein allergens. Serum was obtained from 40 individuals who were skin test-positive to latex; 85% were health care workers. Western blots for IgE reactivity were performed using both ammoniated (AL) and non-ammoniated (NAL) latex proteins and IgE-reactive NAL proteins were analysed by microsequence analysis. The patients were grouped according to common patterns of reactivity. Pattern 1, the most common pattern of reactivity (9/40 patients) recognized two protein bands in both NAL and AL at 46 and 110 kD. A second, heterogeneous pattern of reactivity (pattern 2) recognized a diffuse pattern of polypeptides in the AL preparation. The n-terminal amino acid sequences for allergens at 14, 18, 29, 46 and 110 kD were determined. Sequence analysis identified the 14-kD and 18-kD allergens as the hevein proprotein. The 46-kD and 110-kD had identical sequences which were unique from known latex proteins. We conclude that multiple latex proteins are allergens with hevein preprotein and a previously unidentified 46/110-kD protein being commonly recognized in health care workers.


Subject(s)
Allergens/adverse effects , Allergens/analysis , Dermatitis, Occupational/etiology , Health Personnel , Latex/adverse effects , Latex/analysis , Plant Proteins/adverse effects , Plant Proteins/analysis , Adolescent , Adult , Amino Acid Sequence , Antibody Specificity , Blotting, Western , Child , Female , Humans , Immunodominant Epitopes/adverse effects , Immunodominant Epitopes/analysis , Immunoglobulin E/blood , Immunoglobulin E/metabolism , Male , Middle Aged , Molecular Sequence Data , Plant Proteins/metabolism , Protein Binding , Skin Tests
SELECTION OF CITATIONS
SEARCH DETAIL